EASL Education (@easledu) 's Twitter Profile
EASL Education

@easledu

@EASLedu brings you the latest on #liver research & education. Visit #EASLCampus
-----------------
EASL does not express any political opinion.
RT ≠ endorsement

ID: 4716094827

linkhttp://www.EASLCampus.eu calendar_today05-01-2016 16:05:11

19,19K Tweet

13,13K Followers

728 Following

EASD (@easdnews) 's Twitter Profile Photo

🔖 How are #steatotic liver diseases tackled today? Michael Roden points out innovative aspects of the EASL-EASD-EASO Clinical Practice Guidelines on the management of #MASLD discussed at #EASL2025. 📺 Watch here: tinyurl.com/yspxxpbb 🔗 Guidelines: tinyurl.com/mr3bvb2t

EASL Education (@easledu) 's Twitter Profile Photo

Should we screen for thrombosis risk factors in cirrhosis? NO. 🔹Studies show no added PVT risk from inherited thrombophilia 🔹PVT in cirrhosis is more linked to low portal inflow & local wall stress ➡️ Thrombophilia screening not routinely recommended. @Jhepatology @EASLNews

Should we screen for thrombosis risk factors in cirrhosis?
NO.
🔹Studies show no added PVT risk from inherited thrombophilia
🔹PVT in cirrhosis is more linked to low portal inflow & local wall stress
➡️ Thrombophilia screening not routinely recommended.

@Jhepatology @EASLNews
EASL Education (@easledu) 's Twitter Profile Photo

Who should receive anticoagulation in cirrhosis with PVT? Liver transplant candidates: Treat progressive PVT Non-candidates:Treat if >50% lumen occlusion <50%: Consider surveillance or treatment on a case-by-case basis ⚖️ Decision based on extent, progression, and transplant

Who should receive anticoagulation in cirrhosis with PVT?
Liver transplant candidates: Treat progressive PVT
Non-candidates:Treat if &gt;50% lumen occlusion
&lt;50%: Consider surveillance or treatment on a case-by-case basis
⚖️ Decision based on extent, progression, and transplant
EASL Education (@easledu) 's Twitter Profile Photo

Managing PVT + non-invasive HCC in cirrhosis? ✅ Lower threshold for anticoagulation - even with <50% occlusion ⚠️ Ensure it's not tumoural thrombosis before initiating treatment! @Jhepatology @EASLNews Rautou Pierre-Emmanuel JC Garcia Pagan The Baveno Cooperation: an EASL Consortium Debbie Shawcross #EASLStudio #LiverX

Managing PVT + non-invasive HCC in cirrhosis?
✅ Lower threshold for anticoagulation - even with &lt;50% occlusion
⚠️ Ensure it's not tumoural thrombosis before initiating treatment!

@Jhepatology @EASLNews <a href="/RautouE/">Rautou Pierre-Emmanuel</a> <a href="/jcgarciapagan/">JC Garcia Pagan</a> <a href="/BavenoCoop/">The Baveno Cooperation: an EASL Consortium</a> <a href="/DebbieShawcros1/">Debbie Shawcross</a>
#EASLStudio #LiverX
EASL Education (@easledu) 's Twitter Profile Photo

What kind of anticoagulant should be used in cirrhosis? DOACs? Maybe. But… 🟢Child-Pugh A: Yes 🟠 Child-Pugh B: Caution 🔴 Child-Pugh C: Not recommended ⚠️Watch INR levels ⚠️In transplant setting: Prefer low molecular weight heparins @Jhepatology @EASLNews Rautou Pierre-Emmanuel

What kind of anticoagulant should be used in cirrhosis?
DOACs? Maybe. But…
🟢Child-Pugh A: Yes
🟠 Child-Pugh B: Caution
🔴 Child-Pugh C: Not recommended
⚠️Watch INR levels
⚠️In transplant setting: Prefer low molecular weight heparins

@Jhepatology @EASLNews <a href="/RautouE/">Rautou Pierre-Emmanuel</a>
EASL Education (@easledu) 's Twitter Profile Photo

TIPS and PVT, what’s the risk? 🤔 Will the clot go to the lung? Rarely. TIPS is complex (10% complication rate), bleeding most common. ➡️ Routine anticoagulation post-TIPS? Not recommended. 📊 Depends on individual PVT pathophysiology. @Jhepatology @EASLNews Rautou Pierre-Emmanuel

TIPS and PVT, what’s the risk?
🤔 Will the clot go to the lung? Rarely.
TIPS is complex (10% complication rate), bleeding most common.
➡️ Routine anticoagulation post-TIPS? Not recommended.
📊 Depends on individual PVT pathophysiology.

@Jhepatology @EASLNews <a href="/RautouE/">Rautou Pierre-Emmanuel</a>
EASL Education (@easledu) 's Twitter Profile Photo

Best anticoagulation approach in portal cavernoma? 👉Depends on cause of PVT 👉Always identify fibronoma at first presentation 👉High-risk patients (e.g. thrombophilia, family history): Treat 👉Low recurrence → multidisciplinary decision @Jhepatology @EASLNews Rautou Pierre-Emmanuel

Best anticoagulation approach in portal cavernoma?
👉Depends on cause of PVT
👉Always identify fibronoma at first presentation
👉High-risk patients (e.g. thrombophilia, family history): Treat
👉Low recurrence → multidisciplinary decision

@Jhepatology @EASLNews <a href="/RautouE/">Rautou Pierre-Emmanuel</a>
EASL Education (@easledu) 's Twitter Profile Photo

Splenic artery (true) aneurysm vs pseudoaneurysm True: All 3 layers, mostly splenic, may be genetic Pseudo: Outer wall only, trauma/infection-related 🔺 Pseudo: Always treat 🔺 True: Treat based on size/risk (e.g. >2–2.5 cm, pregnant, transplant setting) @Jhepatology @EASLNews

Splenic artery (true) aneurysm vs pseudoaneurysm 
True: All 3 layers, mostly splenic, may be genetic
Pseudo: Outer wall only, trauma/infection-related
🔺 Pseudo: Always treat
🔺 True: Treat based on size/risk (e.g. &gt;2–2.5 cm, pregnant, transplant setting)

@Jhepatology @EASLNews
EASL Education (@easledu) 's Twitter Profile Photo

🎬 Alas, EASL Studio Season 8 has come to a close. A huge thank you to all the faculty for the insightful discussions this season! 💻 Missed an episode? Catch up on demand via EASL Campus. 🎧 Prefer audio? Tune in on Spotify (with video!), Apple Music, and Amazon Music. 🌞 We’ll

🎬 Alas, EASL Studio Season 8 has come to a close.
A huge thank you to all the faculty for the insightful discussions this season!
💻 Missed an episode? Catch up on demand via EASL Campus.
🎧 Prefer audio? Tune in on Spotify (with video!), Apple Music, and Amazon Music.
🌞 We’ll
LiverAim (@liveraim) 's Twitter Profile Photo

🚀Launching the #LiverRiskScore app! 📱A simple digital tool to spot liver disease risk early using routine clinical data! Easy to use, built for everyday care. 🔗iOS: apps.apple.com/us/app/liverri… 🔗Android play.google.com/store/apps/det… Innovative Health Initiative EASLnews

EMJ Hepatology (@emjhepatology) 's Twitter Profile Photo

EMJ Hepatology is out now! 🔗hubs.la/Q03sQxWT0 Inside, uncover all you need to know from #EASL2025 and beyond - including expert interviews with EASLnews leaders Aleksander Krag and Debbie Shawcross, insights on siRNA and much more.

EASL Education (@easledu) 's Twitter Profile Photo

🚨 New #ReadofTheWeek 🚨 Targeting DHCR7 could offer a new strategy to halt progression of #MetALD and prevent #HCC. ✅ Inhibition reduced steatosis, inflammation, fibrosis & tumour growth in vivo ✅ Validated in 3D human liver spheroids (incl. HCC) 💡 A translational target

EASL Education (@easledu) 's Twitter Profile Photo

It’s that time of the year again 🤩📚👩‍🏫 Dr Brian Hogan opens the #EASLSchool on “Liver Critical Care & Liver Failure”, organised by the teams from the Royal Free Hospital and King’s College 🙏#LiverX EASLnews Prof Rajiv Jalan Debbie Shawcross Sven Francque

It’s that time of the year again 🤩📚👩‍🏫 

Dr Brian Hogan opens the #EASLSchool on “Liver Critical Care &amp; Liver Failure”, organised by the teams from the Royal Free Hospital and King’s College 🙏#LiverX <a href="/EASLnews/">EASLnews</a> <a href="/RajivJalan1/">Prof Rajiv Jalan</a> <a href="/DebbieShawcros1/">Debbie Shawcross</a> <a href="/FrancqueSven/">Sven Francque</a>
EASL Education (@easledu) 's Twitter Profile Photo

➡️State-of-the-art lecture by Prof William Bernal on the epidemiology and current challenges in Acute Liver Failure A brilliant start to the #EASLSchool! 🇬🇧 EASLnews #LiverX Sven Francque Debbie Shawcross Prof Rajiv Jalan

➡️State-of-the-art lecture by Prof William Bernal on the epidemiology and current challenges in Acute Liver Failure 

A brilliant start to the #EASLSchool! 🇬🇧

<a href="/EASLnews/">EASLnews</a> #LiverX <a href="/FrancqueSven/">Sven Francque</a> <a href="/DebbieShawcros1/">Debbie Shawcross</a> <a href="/RajivJalan1/">Prof Rajiv Jalan</a>
Prof Rajiv Jalan (@rajivjalan1) 's Twitter Profile Photo

What a fantastic talk… strong debate about use of plasma exchange in ALF… ‘Not routine’ ‘clear evidence of hemodynamic improvement’ ‘major concern - immunosuppression’

EASL Education (@easledu) 's Twitter Profile Photo

What’s better than one #EASLSchool? Two schools happening at the same time, in the same city! 🙌 🇬🇧 The 2nd one focuses on the management of liver disease in pregnancy 🤰 ➡️ Organised by the fabulous team from Imperial College London 👏 EASLnews #LiverX Imperial College London

What’s better than one #EASLSchool?

Two schools happening at the same time, in the same city! 🙌 🇬🇧

The 2nd one focuses on the management of liver disease in pregnancy 🤰

➡️ Organised by the fabulous team from Imperial College London 👏

<a href="/EASLnews/">EASLnews</a> #LiverX <a href="/imperialcollege/">Imperial College London</a>
EASL Education (@easledu) 's Twitter Profile Photo

Time to put learning into practice! 🧠💡 Students are now working on clinical cases, guided by a fantastic team of experts at the #EASLSchool on the management of liver disease in pregnancy 🤰Imperial College London 🇬🇧 #LiverX EASLnews Debbie Shawcross Sven Francque

Time to put learning into practice! 🧠💡

Students are now working on clinical cases, guided by a fantastic team of experts at the #EASLSchool on the management of liver disease in pregnancy 🤰<a href="/imperialcollege/">Imperial College London</a> 🇬🇧 

 #LiverX <a href="/EASLnews/">EASLnews</a> <a href="/DebbieShawcros1/">Debbie Shawcross</a> <a href="/FrancqueSven/">Sven Francque</a>